Abstract
The human papillomavirus (HPV) 18 L1 gene, which encodes the L1 major capsid protein, was isolated from a female patient in Pusan, Korea Republic and was cloned into pGEX-4T-1 vector. The HPV-18L1 gene was expressed in Escherichia coli as a fusion protein with a glutathione-S-transferase (GST) tag. The soluble recombinant fusion protein, GST-18 L1 fusion, was isolated to high purity. HPV-18 L1 was purified from the GST-18 L1 fusant after biotinylated thrombin cleavage, and then the treated thrombin was removed serially using streptavidin conjugated resin. The purified HPV-18 L1 was confirmed by western blotting using a rabbit anti-denatured papillomavirus polyclonal antibody. The virus-like particles (VLP) from the purified full-length 18 L1 protein without any extra amino acid sequences was observed through the analysis of the electron microscope. This is the first study to report the expression and purification of HPV-18 L1 in E. coli. This expression and purification system offers a simple method of expressing and purifying HPV L1 protein, and could potentially be an effective route for the development and manufacturing of highly purified HPV-18 L1-based cervical cancer vaccines.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Favre, M. (1975) Structural polypeptides of rabbit, bovine, and human papillomaviruses. J. Virol. 15: 1239–1247.
Belnap, D. M., N. H. Olson, N. M. Cladel, W. W. Newcomb, J. C. Brown, J. W. Kreider, N. D. Christensen, and T. S. Baker (1996) Conserved features in papillomavirus and polyomavirus capsids. J. Mol. Biol. 259: 249–263.
Zur Hausen, H. (1999) Papillomaviruses in human cancers. Proc. Assoc. Am. Phys. 111: 581–587.
Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, and K. V. Shah (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87: 796–802.
Burd, E. M. (2003) Human papillomavirus and cervical cancer. Clin. Microbiol. Rev. 16: 1–17.
Yang, E. K., S. W. Jin, B. T. Kang, I. H. Kim, J. K. Park, S. S. Lee, J. W. Kim, and S. N. Park (1998) Construction of artificial epithelial tissue prepared from human normal fibroblasts and C9 cervical epithelial cancer cells carrying human papillomavirus type 18 genes. Biotechnol. Bioprocess Eng. 3: 1–5.
Franco, E. L. and D. M. Harper (2005) Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine 23: 2388–2394.
Muñoz, N, F. X. Bosch, S. de Sanjosé, R. Herrero, X. Castellsagué, K. V. Shah, P. J. Snijders, and C. J. Meijer (2003) Epidemiologioc classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348: 518–527.
Greer, C. E., C. M. Wheeler, M. B. Ladner, K. Beutner, M. Y. Coyne, H. Liang, A. Langenberg, T. S. Yen, and R. Ralston (1995) Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J. Clin. Microbiol. 33: 2058–2063.
Doorbar, J. and P. H. Gallimore (1987) Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a. J. Virol. 61: 2793–2799.
Fang, J. and D. Ewald (2004) Expression cloned cDNA for 10-deacetylbaccatin III-10-O-acetyltransferase in Escherichia coli: a comparative study of three fusion systems. Protein Express. Purif. 35: 17–24.
Zhou, J., X. Y. Sun, D. J. Stenzel, and I. H. Frazer (1991) Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virol. 185: 251–257.
Kirnbauer, R., F. Booy, N. Cheng, D. R. Lowy, and J. T. Schiller (1992) Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. 89: 12180–12184.
Rose, R. C., W. Bonnez, R. C. Reichman, and R. L. Garcea (1993) Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of virus-like particles. J. Virol. 67: 1936–1944.
Sasagawa, T., P. Pushko, G. Steers, S. E. Gschmeissner, M. A. Hajibagheri, J. Finch, L. Crawford, and M. Tommasino (1995) Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe. Virol. 206: 126–135.
Nardelli-Haefliger, D., R. B. Roden, J. Benyacoub, R. Sahli, J. P. Kraehenbuhl, J. T. Schiller, P. Lachat, A. Potts, and P. De Grandi (1997) Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice. Infect. Immun. 65: 3328–3336.
Cho, H. J., H. J. Shin, I. K. Han, W. W. Jung, Y. B. Kim, D. Sul, and Y. K. Oh (2007) Induction of mucosal and systemic immune responses following oral immunization of mice with Lactococcus lactis expressing human papillomavirus type 16 L1. Vaccine 25: 8049–8057.
Kim, S. J., N. J. Kim, C. H. Shin, and C. W. Kim (2008) Optimization of culture condition for the production of D-amino acid oxidase in a recombinant Escherichia coli. Biotechnol. Bioprocess Eng. 13: 144–149.
Son, Y. J., K. H. Park, S. Y. Lee, S. J. Oh, C. K. Kim, B. T. Choi, Y. C. Park, and J. H. Seo (2007) Effects of temperature shift strategies on human preproinsulin production in the fed-batch fermentation of recombinant Escherichia coli. Biotechnol. Bioprocess Eng. 12: 556–561.
Mandic, A. and T. Vujkov (2004) Human papillomavirus vaccine as a new way of preventing cervical cancer: a dream or the future? Ann. Oncol. 15: 197–200.
Banks, L., G. Matlashewski, D. Pim, M. Churcher, C. Roberts, and L. Crawford (1987) Expression of human papillomavirus type 6 and type 16 capsid proteins in bacteria and their antigenic characterization. J. Gen. Virol. 68: 3081–3089.
Meyers, C., J. L. Bromberg-White, J. Zhang, M. E. Kaupas, J. T. Bryan, R. S. Lowe, and K. U. Jansen (2002) Infectious virions produced from a human papillomavirus type 18/16 genomic DNA chimera. J. Virol. 76: 4723–4733.
Hines, J. F., S. J. Ghim, N. D. Christensen, J. W. Kreider, W. A. Barnes, R. Schlegel, and A. B. Jenson (1994) Role of conformational epitopes expressed by human papillomavirus major capsid proteins in the serologic detection of infection and prophylactic vaccination. Gynecol. Oncol. 55: 13–20.
Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248–254.
Woo, M. K., J. M. An, J. D. Park, S. N. Kim, and H. J. Kim (2008) Expression and purification of human papillomavirus 18 L1 virus-like particle from Saccharomyces cerevisiae. Arch. Pharm. Res. 31: 205–209.
Chen, Y., S. J. Ghim, A. B. Jenson, and R. Schlegal (1998) Mutant canine oral papillomavirus L1 capsid proteins which form virus-like particles but lack native conformational epitope. J. Gen. Virol. 79: 2137–2146.
Lee, C., S. G. Lee, S. Takahashi, and B. G.. Kim (2003) The soluble expression of the human rennin binding protein using fusion partners: A comparison of ubiquitin, thioredoxin, maltose binding protein and NusA. Biotechnol. Bioprocess Eng. 8: 89–93.
Chen, X. S., G. Casini, S. C. Harrison, and R. L Garcea (2001) Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1. J. Mol. Biol. 307: 173–182.
Fang, J. and D. Ewald (2004) Expression cloned cDNA for 10-deacetylbaccatin III-10-O-acetyltransferase in Escherichia coli: a comparative study of three fusion systems. Protein Express. Purif. 35: 17–24.
McCarthy, M. P., W. I. White, F. Palmer-Hill, S. Koenig, and J. A. Suzich. (1998) Quantitative disassembly and reassembly of human papillomvirus type 11 virus-like particles in vitro. J. Virol. 72: 32–41.
Zhang, W., J. Carmichael, J. Ferguson, S. Inglis, H. Ashrafian, and M. Stanley (1998) Expression of human papillomavirus type 16 L1 protein in Escherichia coli: denaturation, renaturation, and self-assembly of virus-like particles in vitro. J. Virol. 243: 423–431.
Liao, S., S. Wang, L. Xu, D. Deng, Q. Xu, W. Wang, T. Zhu, X. Bai, J. Zhou, G. Xu, Y. Lu, L. Meng, and D. Ma (2008) Production and verification of human papillomavirus type 18 vaccine in vitro. Oncol. Rep. 20: 211–217.
Biemelt, S., U. Sonnewald, P. Galmbacher, L. Willmitzer, and M. Müller (2003) Production of human papillomavirus type 16 virus-like particles in transgenic plants. J. Virol. 77: 9211–9220.
Petter, A., K. Heim, M. Guger, A. Ciresa-Kö Nig, N. Christensen, M. Sarcletti, U. Wieland, H. Pfister, R. Zangerle, and R. Höpfl (2000) Specific serum IgG, IgM, and IgA antibodies to human papillomavirus types 6, 11, 16, 18, and 31 virus-like particles in human immunodeficiency virus-seropositive women. J. Gen. Virol. 81: 701–708.
Fernandez, J. M. and Hoeffler, J. P. (1999) Gene Expression System: Using nature for the art of expression. Academic Press, San Dieg, CA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Seo, PS., Heo, SY., Han, E.J. et al. Bacterial expression and purification of human papillomavirus type 18 L1. Biotechnol Bioproc E 14, 168–174 (2009). https://doi.org/10.1007/s12257-008-0122-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12257-008-0122-4